Idan Hecht

Idan Hecht

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2016 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
IHIdan Hecht
Idan Hecht
AAAsaf Achiron
Asaf Achiron
VMVitaly Man
Vitaly Man
ZBZvia Burgansky-Eliash
Zvia Burgansky-Eliash

19 August 2017 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
VMVitaly Man
Vitaly Man
IHIdan Hecht
Idan Hecht
MTMichal Talitman
Michal Talitman
AHAssaf Hilely
Assaf Hilely
MMMohamad Midlij
Mohamad Midlij
AAAsaf Achiron
Asaf Achiron

1 July 2020 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
IHIdan Hecht
Idan Hecht
PKPetteri Karesvuo
Petteri Karesvuo
AAAsaf Achiron
Asaf Achiron
Uri ElbazUri Elbaz
Uri Elbaz
ILIlkka Laine
Ilkka Laine
RTRaimo Tuuminen
Raimo Tuuminen

1 April 2020 in Journal of Refractive Surgery
Verified
Journal Article
Closed access
PDF file
BKBoris Knyazer
Boris Knyazer
YKYonit Krakauer
Yonit Krakauer
MTMuhammad Abu Tailakh
Muhammad Abu Tailakh
AAAsaf Achiron
Asaf Achiron
IHIdan Hecht
Idan Hecht
FHFarhad Hafezi
Farhad Hafezi
PURPOSE: To compare the outcomes of accelerated photoactivated chromophore for keratitis corneal cross-linking (PACK-CXL) as an adjunct treatment for bacterial keratitis (PACK-CXL plus standard antibiotic therapy) for patients receiving only standard antibiotic therapy. METHODS: Retrospective cohort study of outcomes of patients with moderate infectious presumed bacterial keratitis (ulcer diameter 2 to 7 mm and stromal depth < 300 µm) were compared before and after initiation of a new treatment protocol of PACK-CXL in addition to standard antibiotic treatment. RESULTS: A total of 70 eyes of 70 patients were included: 39 eyes in the PACK-CXL plus antibiotic (PACK-ABX) group and 31 eyes in the antibiotic only (ABX) control group. The PACK-ABX group showed shorter times to complete reepithelialization (9.3 ± 6.0 vs 16.0 ± 12.7 days, P = .01) and did not require tectonic emergency keratoplasty (0% versus 19.4%, P = .006). The PACK-ABX group also showed a higher percentage of eyes with complete reepithelialization in 6 days or less (46.2% vs 6.5%, P < .001) and a trend for shorter hospitalizations (6.3 ± 5.0 vs 8.5 ± 4.5 days, P = .06). A multivariate analysis controlling for age showed that PACK-ABX treatment remained significantly associated with early ulcer reepithelialization (odds ratio = 0.09, 95% confidence interval = 0.02 to 0.48, P = .005). CONCLUSIONS: This study validates previous findings regarding the use of accelerated PACK-CXL in the treatment of bacterial keratitis. Adding PACK-CXL improved clinical outcomes (reducing healing time) when compared to antibiotics alone. [ J Refract Surg . 2020;36(4):258–264.]

1 March 2021 in Ophthalmology
Verified
Journal Article
Closed access
AAAsaf Achiron
Asaf Achiron
UEUri Elbaz
Uri Elbaz
IHIdan Hecht
Idan Hecht
Oriel SpiererOriel Spierer
Oriel Spierer
AEAdi Einan-Lifshitz
Adi Einan-Lifshitz
RTRaimo Tuuminen
Raimo Tuuminen

8 July 2020 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
IHIdan Hecht
Idan Hecht
BDBiana Dubinsky‐Pertzov
Biana Dubinsky‐Pertzov
PKPetteri Karesvuo
Petteri Karesvuo
AAAsaf Achiron
Asaf Achiron
RTRaimo Tuuminen
Raimo Tuuminen